|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||121.45 - 121.87|
|52 Week Range||99.57 - 123.32|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.20%|
Growth stocks seem likely to keep the upper hand so long as doubts remain about the potential for Washington to come through with tax cuts and infrastructure spending that would give a boost to value.
The market is bleeding with the S&P 500 down 0.78% as of Thursday afternoon -- not a great sign considering it barely moved on Wednesday. Momentum and large-cap growth stocks have been the clear leaders so far this year. The iShares Edge MSCI USA Momentum Factor ETF (MTUM), which I recommended in June, returned more than 18% year-to-date through July, while the iShares Russell 1000 Growth ETF (IWF) returned nearly 14% over the same period.
Year-over-year, Varian Medical Systems (VAR) expects its 4Q17 revenue to be flat or fall. According to the company, headwinds from the euro, British pound, and Japanese yen are expected to have…